Fujita Y - Search Results

1

Vaccination with lipid core peptides fails to induce epitope-specific T cell responses but confers non-specific protective immunity in a malaria model.

Apte SH, Groves PL, Skwarczynski M, Fujita Y, Chang C, Toth I, Doolan DL. Apte SH, et al. Among authors: fujita y. PLoS One. 2012;7(8):e40928. doi: 10.1371/journal.pone.0040928. Epub 2012 Aug 24. PLoS One. 2012. PMID: 22936972 Free PMC article.

2

Investigation toward multi-epitope vaccine candidates using native chemical ligation.

Fujita Y, Moyle PM, Hieu S, Simerska P, Toth I. Fujita Y, et al. Biopolymers. 2008;90(5):624-32. doi: 10.1002/bip.21002. Biopolymers. 2008. PMID: 18979543

3

Design of three-component vaccines against group A streptococcal infections: importance of spatial arrangement of vaccine components.

Abdel-Aal AB, Zaman M, Fujita Y, Batzloff MR, Good MF, Toth I. Abdel-Aal AB, et al. Among authors: fujita y. J Med Chem. 2010 Nov 25;53(22):8041-6. doi: 10.1021/jm1007787. Epub 2010 Oct 28. J Med Chem. 2010. PMID: 21028828

4

Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidates.

Abdel-Aal AB, Batzloff MR, Fujita Y, Barozzi N, Faria A, Simerska P, Moyle PM, Good MF, Toth I. Abdel-Aal AB, et al. Among authors: fujita y. J Med Chem. 2008 Jan 10;51(1):167-72. doi: 10.1021/jm701091d. Epub 2007 Dec 12. J Med Chem. 2008. PMID: 18072728

5

Immunological evaluation of lipopeptide group A streptococcus (GAS) vaccine: structure-activity relationship.

Zaman M, Abdel-Aal AB, Fujita Y, Phillipps KS, Batzloff MR, Good MF, Toth I. Zaman M, et al. Among authors: fujita y. PLoS One. 2012;7(1):e30146. doi: 10.1371/journal.pone.0030146. Epub 2012 Jan 12. PLoS One. 2012. PMID: 22253911 Free PMC article.

6

Structure-activity relationship for the development of a self-adjuvanting mucosally active lipopeptide vaccine against Streptococcus pyogenes.

Zaman M, Abdel-Aal AB, Fujita Y, Ziora ZM, Batzloff MR, Good MF, Toth I. Zaman M, et al. Among authors: fujita y. J Med Chem. 2012 Oct 11;55(19):8515-23. doi: 10.1021/jm301074n. Epub 2012 Sep 25. J Med Chem. 2012. PMID: 22974133

7

Toward the development of prophylactic and therapeutic human papillomavirus type-16 lipopeptide vaccines.

Moyle PM, Olive C, Ho MF, Pandey M, Dyer J, Suhrbier A, Fujita Y, Toth I. Moyle PM, et al. Among authors: fujita y. J Med Chem. 2007 Sep 20;50(19):4721-7. doi: 10.1021/jm070287b. Epub 2007 Aug 17. J Med Chem. 2007. PMID: 17705361

8

Development of a liposaccharide-based delivery system and its application to the design of group A streptococcal vaccines.

Simerska P, Abdel-Aal AB, Fujita Y, Moyle PM, McGeary RP, Batzloff MR, Olive C, Good MF, Toth I. Simerska P, et al. Among authors: fujita y. J Med Chem. 2008 Mar 13;51(5):1447-52. doi: 10.1021/jm701410p. Epub 2008 Feb 16. J Med Chem. 2008. PMID: 18278857

9

Synthesis and in vivo studies of carbohydrate-based vaccines against group A streptococcus.

Simerska P, Abdel-Aal AB, Fujita Y, Batzloff MR, Good MF, Toth I. Simerska P, et al. Among authors: fujita y. Biopolymers. 2008;90(5):611-6. doi: 10.1002/bip.20992. Biopolymers. 2008. PMID: 18381625

10

Synthesis and immunological evaluation of self-adjuvanting glycolipopeptide vaccine candidates.

Fujita Y, Abdel-Aal AB, Wimmer N, Batzloff MR, Good MF, Toth I. Fujita Y, et al. Bioorg Med Chem. 2008 Oct 1;16(19):8907-13. doi: 10.1016/j.bmc.2008.08.064. Epub 2008 Aug 29. Bioorg Med Chem. 2008. PMID: 18789866

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,512 results

Search Page

Filters